Chlamydia trachomatis (CT)

Roche supports diagnostic laboratories and healthcare professionals in the swift, accurate detection of Chlamydia and other sexually transmitted infections.1

As a pioneer in the field of PCR, Roche supports diagnostic laboratories and healthcare professionals in the swift, accurate detection of Chlamydia trachomatis and other sexually transmitted infections.

If left untreated, chlamydial infections can result in serious health problems, including infertility and vision impairment.

An increase in patient awareness campaigns and government health initiatives are expected to increase demand for testing in the future, with regular screening recommended in many countries for young, sexually active women in particular.

Reference:

  1. Global Burden of Disease Study 2013, Collaborators (22 August 2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015:368(9995):743-800. PMID 26063472.